ACS (excluding AMI): 1 trials - Prandoni
All type of patients: 1 trials - Prandoni
13 trials - Ekestrom - GESIC (aspirin+dipyridamol) - Basel - Brussels - Thaulow - Toronto dipyridamole - Czech - Brooks - Leeds-B - Wadsworth - Mayo-A - Des Moines - Pantely
Secondary prevention in patients with CAD: 13 trials - PARIS-II - PARIS - PARIS - Igloe - Atlanta (Sbar) - Becker - Wirecki - Leiberman - Neumann - Kinsella - Dewar - Zion - Foulds
Secondary prevention in patients with intermittent claudication: 3 trials - VA study - Hess (2) - Schoop (2)
13 trials - PARIS-II - PARIS - PARIS - Igloe - Atlanta (Sbar) - Becker - Wirecki - Leiberman - Neumann - Kinsella - Dewar - Zion - Foulds
4 trials - White (aspirin+dipiridamol) - Nye (Dunedin) - Mayo-PTCA - Schwartz (Toronto)
3 trials - VA study - Hess (2) - Schoop (2)
All type of patient: 3 trials - PARIS-II - PARIS - PARIS
All type of patients: 3 trials - PARIS-II - PARIS - PARIS
10 trials - Igloe - Atlanta (Sbar) - Becker - Wirecki - Leiberman - Neumann - Kinsella - Dewar - Zion - Foulds
All type of patients: 12 trials - Harjola DVT - Toulouse I - Weiss - Zekert-III - Australian II - Encke IA - Encke IB - Hamburg - Australian I - Lyon-I - Parodi I - Parodi II
Elective orthopedic surgery: 2 trials - Hamburg - Lyon-I
General surgery: 10 trials - Harjola DVT - Toulouse I - Weiss - Zekert-III - Australian II - Encke IA - Encke IB - Australian I - Parodi I - Parodi II
Medical patients: 2 trials - Chicago - Frankfurt
Orthopedic surgery: 5 trials - Morris-A - Morris-B - Encke-II - Hamburg - Lyon-I